85 related articles for article (PubMed ID: 26936116)
1. Forced expression of Nanog with mRNA synthesized in vitro to evaluate the malignancy of HeLa cells through acquiring cancer stem cell phenotypes.
Ding Y; Yu AQ; Wang XL; Guo XR; Yuan YH; Li DS
Oncol Rep; 2016 May; 35(5):2643-50. PubMed ID: 26936116
[TBL] [Abstract][Full Text] [Related]
2. TALEN-mediated Nanog disruption results in less invasiveness, more chemosensitivity and reversal of EMT in Hela cells.
Ding Y; Yu AQ; Li CL; Fang J; Zeng Y; Li DS
Oncotarget; 2014 Sep; 5(18):8393-401. PubMed ID: 25245189
[TBL] [Abstract][Full Text] [Related]
3. Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation.
Kumar SM; Liu S; Lu H; Zhang H; Zhang PJ; Gimotty PA; Guerra M; Guo W; Xu X
Oncogene; 2012 Nov; 31(47):4898-911. PubMed ID: 22286766
[TBL] [Abstract][Full Text] [Related]
4. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
[TBL] [Abstract][Full Text] [Related]
5. Doxycycline Induces Apoptosis and Inhibits Proliferation and Invasion of Human Cervical Carcinoma Stem Cells.
Yang B; Lu Y; Zhang A; Zhou A; Zhang L; Zhang L; Gao L; Zang Y; Tang X; Sun L
PLoS One; 2015; 10(6):e0129138. PubMed ID: 26111245
[TBL] [Abstract][Full Text] [Related]
6. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
[TBL] [Abstract][Full Text] [Related]
7. STAT3 correlates with stem cell-related transcription factors in cervical cancer.
Wang H; Cai HB; Chen LL; Zhao WJ; Li P; Wang ZQ; Li Z
J Huazhong Univ Sci Technolog Med Sci; 2015 Dec; 35(6):891-897. PubMed ID: 26670442
[TBL] [Abstract][Full Text] [Related]
8. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma.
Tsai LL; Yu CC; Chang YC; Yu CH; Chou MY
J Oral Pathol Med; 2011 Sep; 40(8):621-8. PubMed ID: 21342274
[TBL] [Abstract][Full Text] [Related]
9. Evaluating of OCT-4 and NANOG was differentially regulated by a new derivative indole in leukemia cell line.
Karimabad MN; Mahmoodi M; Jafarzadeh A; Darehkordi A; Hajizadeh MR; Khorramdelazad H; Sayadi AR; Rahmani F; Hassanshahi G
Immunol Lett; 2017 Oct; 190():7-14. PubMed ID: 28690187
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-145 inhibits tumorigenesis and invasion of cervical cancer stem cells.
Zhou X; Yue Y; Wang R; Gong B; Duan Z
Int J Oncol; 2017 Mar; 50(3):853-862. PubMed ID: 28112371
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.
Ma L; Lai D; Liu T; Cheng W; Guo L
Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):593-602. PubMed ID: 20705681
[TBL] [Abstract][Full Text] [Related]
12. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
13. [Effect and mechanism of an autophagy gene beclin 1 on cervical cancer HeLa cells].
Wang ZH; Li L; Duan ZL
Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):125-31. PubMed ID: 21426771
[TBL] [Abstract][Full Text] [Related]
14. Molecular iodine inhibits the expression of stemness markers on cancer stem-like cells of established cell lines derived from cervical cancer.
Bigoni-Ordóñez GD; Ortiz-Sánchez E; Rosendo-Chalma P; Valencia-González HA; Aceves C; García-Carrancá A
BMC Cancer; 2018 Sep; 18(1):928. PubMed ID: 30257666
[TBL] [Abstract][Full Text] [Related]
15. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas.
Guo Y; Liu S; Wang P; Zhao S; Wang F; Bing L; Zhang Y; Ling EA; Gao J; Hao A
Histopathology; 2011 Oct; 59(4):763-75. PubMed ID: 22014056
[TBL] [Abstract][Full Text] [Related]
16. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.
Chiou SH; Wang ML; Chou YT; Chen CJ; Hong CF; Hsieh WJ; Chang HT; Chen YS; Lin TW; Hsu HS; Wu CW
Cancer Res; 2010 Dec; 70(24):10433-44. PubMed ID: 21159654
[TBL] [Abstract][Full Text] [Related]
17. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.
Chiou SH; Yu CC; Huang CY; Lin SC; Liu CJ; Tsai TH; Chou SH; Chien CS; Ku HH; Lo JF
Clin Cancer Res; 2008 Jul; 14(13):4085-95. PubMed ID: 18593985
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin B in cervical cancer: critical for the maintenance of cancer stem-like cell characters.
Tian Y; Ding W; Wang Y; Ji T; Sun S; Mo Q; Chen P; Fang Y; Liu J; Wang B; Zhou J; Ma D; Wu P
PLoS One; 2013; 8(12):e84457. PubMed ID: 24367661
[TBL] [Abstract][Full Text] [Related]
19. Lurbinectedin (PM01183), a selective inhibitor of active transcription, effectively eliminates both cancer cells and cancer stem cells in preclinical models of uterine cervical cancer.
Yokoi E; Mabuchi S; Shimura K; Komura N; Kozasa K; Kuroda H; Takahashi R; Sasano T; Kawano M; Matsumoto Y; Kodama M; Hashimoto K; Sawada K; Kimura T
Invest New Drugs; 2019 Oct; 37(5):818-827. PubMed ID: 30374654
[TBL] [Abstract][Full Text] [Related]
20. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]